may be a beneficial practice for neonates with ostomy placements.
"The expected benefits of reinfusing succus entericus are to prevent atrophy of the distal gastrointestinal tract and to allow normal digestion and absorption of nutrients, electrolytes, minerals, and fluid."
Clinical Research Reports
Abstract: Background. Neonates who undergo surgery and have an ostomy with a creation of a mucous fistula are at nutritional risk, especially if the ostomy placement is proximal and the remaining bowel is not being used. Total parenteral nutrition (TPN) is used to maintain the neonatal nutritional status, but long-term use is associated with increased morbidities. The concept of reinfusing succus entericus into the mucous fistula to decrease the neonate's dependence on TPN has been limited to case reports. Methods. This is a retrospective cohort study documenting the effectiveness of reinfusing succus entericus into the mucous fistula for neonates admitted to the neonatal intensive care unit (NICU). The authors' primary hypothesis was that neonates who had succus entericus reinfused into the mucous fistula had decreased dependence on TPN. Results. Of the premature infants receiving mucous fistula feedings, 65% had TPN discontinued, whereas 67% of the term infants had TPN discontinued. The type of ostomy affected the neonate's ability to be weaned off TPN. In all, 80% of the neonates with ileostomies were able to have TPN discontinued as compared with only 38% of the neonates with jejunostomies. Conclusions. The reinfusion of succus entericus into the mucous fistula decreases the neonate's dependence on TPN and may prevent the progression of TPN-related morbidities from long-term use. Reinfusion of succus entericus into the mucous fistula
Introduction
Neonates who undergo a surgical resection for a gastrointestinal disorder may require creation of an ostomy, which can increase their risk for morbidity and mortality. 1 Depending on the type of ostomy created, it may cause functional shortbowel syndrome because of decreased bowel surface area available to digest and absorb nutrients and fluids. This decreased absorption capacity can place the neonate at risk for malnutrition and fluid imbalances, especially if the ostomy is in the proximal small bowel and the remaining portion of the bowel is not being used. To compensate for the decreased absorptive capabilities, these neonates are placed on total parenteral nutrition (TPN) to meet their nutritional and hydration needs. Although TPN can effectively meet their nutritional needs, neonates receiving TPN for greater than 2 weeks can experience TPN-related morbidities. Neonates who are dependent on long-term TPN to provide the majority of their nutrition are at risk of developing cholestasis, 2 osteopenia, 3 sepsis, 4,5 and growth failure. 6 Previous studies have shown that reinfusion of succus entericus (intestinal juice) through the mucous fistula decreased or eliminated a neonate's dependence on TPN. [7] [8] [9] [10] To prevent TPN-related morbidities, it has been the practice at the neonatal intensive care unit (NICU) at Children's Hospital of Illinois at OSF Saint Francis Medical Center, Peoria IL, to collect and reinfuse the succus entericus output from the ostomy into the mucous fistula. The expected benefits of reinfusing succus entericus are to prevent atrophy of the distal gastrointestinal tract and to allow normal digestion and absorption of nutrients, electrolytes, minerals, and fluid. Using the distal portion of the gastrointestinal tract allows the TPN volume to be decreased or even for TPN to be discontinued.
The purpose of this study is to document the effect of our practice (Table 1) of reinfusing succus entericus into the mucous fistula and its effect on reducing a surgical neonate's dependence on TPN.
Methods
The research design for this study was a retrospective cohort study. All the neonates admitted to the NICU between January 2000 to December 2010 who had one of the following International Statistical Classification of Diseases 9 Codes (ICD9) were screened: 45.33 local excision of lesion or tissue of small intestine, except duodenum; 45.41 excision of lesion or tissue of large intestine; 46.10 colostomy, not otherwise specified; 46.20 ileostomy, not otherwise specified; 46.11 temporary colostomy; 46.21 temporary ileostomy; 46.13 permanent colostomy; 46.23 other permanent ileostomy; or 54.11 exploratory laporotomy. A total of 125 medical records of surgical neonates admitted to the NICU during this period were identified. Their medical records were reviewed to determine if an order was written to begin reinfusion of succus entericus into the mucous fistula. If reinfusion was ordered, we collected the following data from the patient's medical record: gestational age (GA), birth weight, gender, surgical diagnosis, surgical procedure, extent of bowel resection, location of enterostomy and mucus fistula, type of enteral formula used, ratio of TPN versus enteral feedings, whether TPN was discontinued, average weight gain during reinfusion of succus entericus, postmenstrual age when bowel continuity was reestablished, and average weight gain after reversal of enterostomy.
Premature infants were classified as any infant born at less than 37 weeks' GA. The formula categories were defined as follows: premature formulas, those infants who received a premature formula or an enriched discharge formula, which is specifically designed for premature or low-birth-weight infants; fortified breastmilk, any infant who received human milk fortifier or whose breastmilk was fortified beyond 20 cal/oz Table 1 .
Guidelines for Mucous Fistula Refeedings
1. Create a special port to the current ostomy bag, or obtain a new ostomy bag and create a special port for red catheter tubing 2. Insert a red rubber catheter tube through the port in the ostomy bag, and insert red rubber catheter tubing into the mucous fistula approximately 2 inches or far enough, so that the tubing cannot be dislodged 3. Secure the red rubber catheter to the bag with tube gauze tape transpore so that it does not get dislodged from the stoma 4. Attach enteral tubing to the red rubber catheter's open end for future refeeding 5. Every 8 hours, collect the succus entericus output from the ostomy bag and store in an enteral feeding syringe 6. Attach the enteral feeding syringe to the enteral tubing. Place on an enteral pump and feed succus entericus into the mucous fistula over 4 to 8 hours, per doctor's order Troubleshooting a. If the enteral feeding pump frequently becomes occluded, change to a Kangeroo Pump b. If succus entericus viscosity becomes too thick to be administered by an enteral feeding system, obtain a physician order to add Pedialyte (or equivalent) to dilute succus entericus c. If both stomas are in the same ostomy bag, it may be difficult to determine if the "refeed" is leaking out of stoma during your attempt to feed d. Occasionally, the stored succus entericus builds up "gas" in the syringe, so having a proper storage place is essential to prevent unwanted losses or potential contamination with an infant formula powder; elemental formula, any infant who received amino acid-based infant formula; and Pregestimil (Mead Johnson, IN), which contains 55% of the fat calories as medium-chain triglycerides. Continuous feedings were given hourly over a 24-hour period. Bolus feedings were provided every 3 hours. The ratio of enteral to TPN volumes was calculated by taking the enteral feedings in milliliters and TPN solution in milliliters and dividing each by the total volume of both mediums over a 24-hour period. Average weight gain was determined by taking the daily weights in kilograms and dividing the gain over a 7-day period.
Statistical Analysis
Pearson χ 2 was used to compare the differences between the 2 groups for most of the categorical variables. When there was an empty cell, the Fisher's test was used. For the continuous variables, the 2-sample t tests were performed when it was determined that the variables had a normal distribution. The Mann-Whitney U test was used when it was determined that the variables did not have a normal distribution. Means and standard deviations were reported for continuous variables. Frequency and percentages were reported for categorical variables. The 2-tailed P values were calculated for all tests, and P < .05 was considered for statistical significance. All statistical analyses were performed using SPSS 17.0 (SPSS Inc, Chicago, IL).
Results
A total of 40 infants were identified as having had orders for reinfusion of succus entericus following creation of enterostomy with mucus fistula during the study period. Of these infants, 6 were excluded because succus entericus reinfusion was never initiated; 2 were excluded because they expired, and 1 was excluded for having had reinfusion of succus entericus for only about 6 hours. One was excluded for incomplete data. Data pertaining to the remaining 29 infants were analyzed.
Demographics
The demographic distribution for infants in this analysis is given in Table  2 . The mean GA at birth was 30.3 ± 6 weeks (23-41 weeks), with an average birth weight of 1635 ± 1146 g (495-3970 g). Of the infants, 52% were male and 48% female; 10% of the infants were classified as small for GA, 86% of the infants were appropriate for GA, and 4% of the infants were large for GA at birth. A total of 79 infants were born premature (<37 weeks GA), and 21% of the infants were born at term. The percentages for various surgical diagnoses (Table 3) for the premature infants (n = 23) were as follows: necrotizing enterocolitis, 22%; perforations, 30%; necrotizing enterocolitis with perforation, 22%; malrotation, 4%; and other diagnoses that required surgical intervention, 22%. For term infants (n = 6), 50% of the infants had a surgical diagnosis of atresia, 17% were diagnosed with malrotation, and 33% had other types of surgical diagnoses. Of the premature infants, 35% had a jejunostomy, and 65% had an ileostomy; 83% of the term infants had an ileostomy, and 17% had a colostomy.
Type of Formula and Feeding Mode
Information pertaining to type of formula and feeding mode is given in Table  4 . It was found that 21% of the premature infants' diet order during mucous fistula refeedings was preterm formula, 39% received breastmilk with human milk fortifier, 4% received unfortified breastmilk, 18% received an elemental formula (Elecare, Abbott Nutrition or Neocate, SHS), and 13% received a hydrolyzed formula (Pregestimil, Mead Johnson). All the term infants received an elemental formula for their diet order during reinfusion. Of the premature infants, 57% were on continuous feedings during reinfusion, and 50% of the term infants received continuous feedings during reinfusion; 39% of the premature infants received bolus feedings during reinfusion, and 50% of the term infants received bolus feeding during reinfusion. Once the infants underwent reanastomosis and were restarted on enteral feedings, 31% of the premature infants went home on an enriched formula, 26% were discharged home on fortified breastmilk, 39% were discharged home on an elemental formula, and 4% were discharged home on a hydrolyzed formula. Once term infants underwent reanastomosis and had enteral feedings restarted, 17% were discharged home on an enriched formula, and 83% of the infants remained on an elemental formula at the time of discharge.
Tolerance to Reinfusion of Succus Entericus Table 5 contains information on the neonate's tolerance to mucous fistula reinfusion of succus entericus. Premature infants averaged a weight gain of 22 ± 8 gm/d during the period of reinfusion and 24 ± 14 gm/d once reconnected and until discharge. Term infants averaged a weight gain of 24 ± 14 g/d during the period of reinfusion and 14 ± 11 g/d once reconnected and until discharge. Of the premature infants, 65% were able to be weaned off TPN, whereas 67% of the term infants were able to be weaned off TPN prior to reanastomosis. Premature infants were able to receive 80% ± 30% of their feeding enterally before reanastomosis, whereas term infants were able to receive 85% ± 24% of their feeding enterally before reanastomosis.
Comparison of Type of Ostomy Placement
The differences between jejunostomies versus ileostomies for premature infants are given in Table 6 . Of the premature infants who had an ileostomy, 80% were able to have TPN discontinued versus only 38% of the infants with a jejunostomy, which was significant (P = .042). Of the infants with jejunostomies, 63% were fed continuously, and 43% were fed by bolus feeding, which was not significantly different (P = .806). Weight gains between the 2 types of ostomies were not significantly different. Infants with jejunostomies had an average weight gain of 20.3 ± 9 g during mucous fistula reinfusion, whereas infants with ileostomies had an average weight gain of 22.2 ± 8 g during mucous fistula reinfusion (P = .612).
Discussion
The primary hypothesis for this study was that neonates who underwent mucous fistula reinfusion of success entericus would decrease their dependence on TPN. Our analysis showed that 65% of the premature infants and 67% of the term infants were able to be weaned off TPN. The infants who continued receiving TPN were able to tolerate obtaining a majority of their caloric needs from enteral nutrition. Premature infants averaged 80% ± 30% of their calories from enteral nutrition, whereas term infants averaged 85% ± 24% of their calories from enteral nutrition. The goal of the NICU at Children's Hospital of Illinois at OSF Saint Francis Medical Center is to begin enteral feedings in postsurgical neonates once bowel function returns. It is our standard of practice to begin minimal enteral nutrition for at least 4 days before advancing enteral feedings. A study by Ekingen et al 11 found that postsurgical infants achieved full enteral feedings significantly sooner when enteral feedings were initiated within 12 hours after surgery. Using mucous fistula reinfusion allowed for higher volume advancement of enteral feedings, therefore allowing the clinicians to decrease the TPN volume. There are other case reports documenting the effectiveness of mucous fistula reinfusion in neonates. A study by Al-Harbi et al 7 described 6 neonates between the GAs of 27 to 38 weeks and how 5 infants were able to be weaned off of their dependence on TPN and averaged a weight gain of between 5 and 25 g/d until reanastomosis could occur. Another study by Wong et al 9 demonstrated that 12 premature infants between 24 and 27 weeks' GA were able to establish mucous fistula reinfusion in all patients without any complications. It was found that infants had improved weight gains after mucous fistula reinfusion was started-18.9 ± 2.9 g versus 10.5 ± 1.5 g/d before reinfusions were initiated. Even with mucous fistula reinfusion, 42% of the infants still developed cholestatic jaundice. 9 A systematic review by Richardson et al 12 found that neonates had better weight gains when receiving a combination of TPN and mucous fistula reinfusion versus TPN alone. All the neonates analyzed were able to have their TPN volumes decreased when receiving mucous fistula reinfusions, which resulted in reducing their risk for cholestatic jaundice. 12 Finally, neonates who had mucous fistula reinfusion were able to be reanastomosed sooner, and it was postulated that this shortened time was a result of feeding the distal portion of the bowel, therefore encouraging intestinal adaptation. 12 The limitations to the systematic review by Richardson et al 12 was restricted to small case reports and isolated reports. Even though our study is not a randomized controlled trial, it involves the largest study population for which the outcomes of mucous fistula reinfusion were analyzed.
The type of ostomy created probably had an effect on which neonates were able to successfully wean off TPN. Only 38% of the premature infants with a jejunostomy were able to be weaned off TPN, whereas 80% of the premature infants with an ileostomy were able to be weaned off TPN. The issue with a jejunostomy is that it causes the neonate to have less surface area to absorb nutrients. The jejunum is a primary site for nutrient absorption. When infants undergo a jejunal resection they are at risk for the onset of nutrient deficiencies of major substrates, minerals, and vitamins. 13 The main principle behind advocating the practice of mucous fistula reinfusion is to allow the continuation of the digestive and absorptive process because the ileum has a better adaptability of function than the jejunum after a resection. 13 Although using TPN to maintain a neonate's nutrition may be beneficial in the short term, TPN alone without the initiation of enteral nutrition is associated with morphological and functional changes in the gut as indicated by decreases in intestinal mass, decrease in enzyme activity, and an increase in gut permeability. 14 An obstacle when beginning enteral feedings in neonates with ostomies, especially proximal jejunostomies, is gastric hypersecretion. Two factors that stimulate gastric hypersecretion are massive bowel resection and the initiation of enteral feedings. 15 Gastric hypersecretion can continue for 2 to 5 weeks after surgery. 15 Not only does the large succus entericus output make it impractical for nursing to reinfuse 100% of the volume, but the excess gastric secretion can interfere with nutrient absorption. 16 Intravenous ranitidine can be prescribed to treat gastric hypersecretion. Ranitidine therapy has been shown to be effective at reducing gastric secretions by approximately 50%. 16 Clinicians may want to begin ranitidine therapy during mucous fistula reinfusion to keep the succus entericus output at a manageable level, so that the neonate can continue to digest and absorb 100% of the nutrients provided during the mucous fistula reinfusion.
The type of feeding mode may have contributed to an infant's ability to be weaned off TPN. For infants with short-bowel syndrome, studies have shown that using continuous enteral feedings assists with bowel adaptation. [17] [18] [19] [20] Providing continuous feedings can enhance absorption, decrease TPN dependence, and reduce hepatic injury often caused by TPN. Parker et al 18 found that by providing continuous feedings to infants with surgically created short-bowel syndrome, they had a better energy balance of nutrients, less diarrhea, and significant increases in body weight when compared with intermittent feedings. Most of the infants in this study had functional short-bowel syndrome because of their ostomies. Providing continuous enteral feedings can reduce volume output from the stoma and allow for better absorption of nutrients. Neonates who are developmentally appropriate for age should be provided an opportunity to nipple small amounts of formula 2 to 3 times per day.
The type of enteral feeding used during mucous fistula refeeding can greatly affect the tolerance and ability to progress on the enteral feeding volume.
Research has suggested the use of amino acid-based formulas, and breastmilk may assist with improving bowel adaptation, allowing for enteral feedings to be advanced and TPN volume decreased. 21, 22 The issue with using an amino acidbased formula for very premature infants is that it will not meet their nutritional requirements for nutrients such as protein, calcium, and phosphorus. In our study, 22% of the premature infants were able to tolerate and gain weight appropriately when prescribed a premature formula. The largest percentage of fat calories present in premature formulas is medium-chain triglycerides, which can be directly absorbed into the portal vein and potentially improve feeding tolerance. Premature formulas do contain intact protein unlike the amino acidbased formulas. A randomized trial of term infants by Ksiazyk et al 23 found that intestinal permeability, energy, and nitrogen balance were not affected when comparing formulas containing hydrolyzed versus nonhydrolyzed whey protein diets. Premature formulas contain medium-chain triglycerides as their largest percentage of fat calories. The advantage of medium-chain triglycerides is that they can be directly absorbed into the portal vein, thereby potentially improving feeding tolerance. 24 The use of breastmilk for infants with short-bowel syndrome has been shown to decrease their dependence on TPN. 22 We found that 43% of the premature infants in this study were able to tolerate their own mother's breastmilk (unfortified and fortified combined). Breastmilk contains properties that can have a trophic affect on the gastrointestinal tract. Epidermal growth factor, insulin-like growth factor-1, and growth factors present in breastmilk have been shown to have a strong trophic affect on intestinal cells. 25 Another advantage of using breastmilk over formula is that breastmilk is the only substrate that will decrease intestinal permeability; therefore, it may reduce an infant's risk for developing sepsis as a result of bacterial translocation. 26, 27 The limitations of this study were its retrospective design and the fact that the mucous fistula reinfusion was not standardized for mode of feeding or the type of formula used during the reinfusion. These variances may have limited their level of significance for identifying which feeding technique could maximize feeding tolerance and promote optimal weight gain.
This study supports our hypothesis that mucous fistula reinfusion is beneficial for neonates who have undergone a bowel resection with creation of an ostomy. Clinicians should use mucous fistula reinfusion to decrease a neonate's dependence on TPN and the morbidities associated with long-term TPN use. Also, mucous fistula reinfusion has the potential to reduce the cost of providing care to these infants by reducing TPN-associated morbidity. Finally, mucous fistula reinfusion allows the process of digestion and absorption of nutrients to continue in the distal bowel-thereby reducing the risk of feeding intolerance-following reanastomosis because it can prevent gut atrophy of the distal portion of the bowel.
